SCHEMBL959562

SCHEMBL959562

COc1nn(C)c(=O)n1-c1ccccc1CO/N=C(/C)c1cccc(C(F)(F)F)c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
PPARG P37231 3/20 0.37
PPARA Q07869 3/20 0.37
NPSR1 Q6W5P4 1/20 0.35
POLB P06746 1/20 0.35
MAOB P27338 2/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
LMNA P02545 2/20 0.33
GAA P10253 2/20 0.33
MAOA P21397 1/20 0.33
HTR2A P28223 1/20 0.33
ABHD6 Q9BV23 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32678199 1.00 KMT2A (0.37) KMT2AMEN1PPARGPPARANPSR1
SCHEMBL29870686 1.00 KMT2A (0.37) KMT2AMEN1PPARGPPARANPSR1
SCHEMBL119998 1.00 KMT2A (0.37) KMT2AMEN1PPARGPPARANPSR1
SCHEMBL119997 1.00 KMT2A (0.37) KMT2AMEN1PPARGPPARANPSR1
SCHEMBL9049391 0.89 KMT2A (0.38) KMT2AMEN1PPARGPPARANPSR1
SCHEMBL9049388 0.89 KMT2A (0.38) KMT2AMEN1PPARGPPARANPSR1
SCHEMBL8155257 0.89 GAA (0.34) KMT2AMEN1NPSR1POLBMAOB
SCHEMBL8155255 0.89 GAA (0.34) KMT2AMEN1NPSR1POLBMAOB
SCHEMBL13490744 0.88 KMT2A (0.40) KMT2AMEN1PPARGPPARANPSR1
SCHEMBL8658637 0.88 PPARG (0.38) KMT2AMEN1PPARGPPARANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462805-A1 Formulations containing stabilised compounds containing iodine LANXESS Deutschland GmbH (DE) 2012-06-13 EP claimed
WO-2007101547-A2 SYNERGISTIC COMBINATIONS OF ACTIVE INGREDIENTS BAYER CROPSCIENCE AG (DE) 2007-09-13 WO claimed
EP-1506711-A2 Fungicidal combinations of active agents Bayer CropScience AG (DE) 2005-02-16 EP claimed
US-20040266850-A1 Fungicidal active ingredient combinations WACHENDORFF-NEUMANN ULRIKE (DE) 2004-12-30 US claimed
EP-1289366-B1 FUNGICIDAL COMBINATIONS OF ACTIVE AGENTS BAYER CROPSCIENCE AG (DE) 2004-06-30 EP claimed
US-20030229087-A1 Fungicidal combinations of active agents BAYER AKTIENGESELLSCHAFT (DE) 2003-12-11 US claimed
US-6624183-B2 Combinations of a fluoro-benzothiazole of the formula (I) find use as fungicides. BAYER AKTIENGESELLSCHAFT (DE) 2003-09-23 US claimed
EP-1239733-B1 FUNGICIDAL COMBINATIONS OF ACTIVE SUBSTANCES BAYER CROPSCIENCE AG (DE) 2003-07-02 EP claimed
US-20030105146-A1 Fungicidal combinations of active substances BAYER AKTIENGESELLSCHAFT (DE) 2003-06-05 US claimed
JP-2003516979-A 2003-05-20 JP claimed
EP-0967869-B1 FUNGICIDAL MIXTURES DU PONT (US) 2003-04-16 EP claimed
EP-1289366-A1 FUNGICIDAL COMBINATIONS OF ACTIVE AGENTS Bayer Aktiengesellschaft (DE) 2003-03-12 EP claimed
EP-1276375-A2 FUNGICIDAL ACTIVE INGREDIENT COMBINATIONS Bayer Aktiengesellschaft (DE) 2003-01-22 EP claimed
EP-1239733-A2 FUNGICIDAL COMBINATIONS OF ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2002-09-18 EP claimed
WO-2001084931-A1 FUNGICIDAL COMBINATIONS OF ACTIVE AGENTS BAYER CROPSCIENCE AG (DE) 2001-11-15 WO claimed
WO-2001080641-A2 FUNGICIDAL ACTIVE INGREDIENT COMBINATIONS BAYER CROPSCIENCE AG (DE) 2001-11-01 WO claimed
WO-2001044215-A2 FUNGICIDAL COMBINATIONS OF ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2001-06-21 WO claimed
EP-0967869-A1 FUNGICIDAL MIXTURES E.I. DU PONT DE NEMOURS & COMPANY INCORPORATED (US) 2000-01-05 EP claimed
WO-1998033382-A1 FUNGICIDAL COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-08-06 WO claimed
WO-1998033381-A1 FUNGICIDAL MIXTURES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-08-06 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105146-A1 Fungicidal combinations of active substances CYP1B1, CYP4X1, CYP1A1 KMT2A 2242/4885MEN1 2062/4885PPARG 1942/4885
US-20040266850-A1 Fungicidal active ingredient combinations CYP1A1, NAT1, CYP2E1 KMT2A 787/4885MEN1 368/4885PPARG 3005/4885
US-20030229087-A1 Fungicidal combinations of active agents CYP51A1, ERG28, DPM1 KMT2A 3228/4885MEN1 1005/4885PPARG 4032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.